← Back to Clinical Trials
Recruiting NCT06791850

NCT06791850 Sustaining Home Heart Failure Palliative Care in Rural Appalachia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06791850
Status Recruiting
Phase
Sponsor West Virginia University
Condition Heart Failure NYHA Class III
Study Type INTERVENTIONAL
Enrollment 208 participants
Start Date 2025-04-01
Primary Completion 2028-04-01

Eligibility & Interventions

Sex All sexes
Min Age 45 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
HF-FamPALhomeCARE

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 208 participants in total. It began in 2025-04-01 with a primary completion date of 2028-04-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this mixed methods randomized controlled trial is to test the integrated nurse-led intervention bundle for family home care management of end-stage heart failure and palliative care in rural Appalachia. This intervention bundle is designed to address rural disparities in access to health care, with the help of the faith-based nurses and local volunteer visiting neighbors.

Eligibility Criteria

Inclusion Criteria: 1. Adult patients' age between 50 to 80 years with advanced HF (NYHA III or IV), diagnosed by physician 2. Caregivers' age between 45 to 80 years. 3. Alert and consent to participate 4. Able to read and understand English Exclusion Criteria: 1. Already received or are on a waiting list for a heart transplant or left ventricular assist device (LVAD) 2. Diagnosed with a terminal illness or dementia, such as Alzheimer's disease

Contact & Investigator

Central Contact

Ubolrat Piamjariyakul

✉ ubolrat.piamjariyakul@hsc.wvu.edu

📞 304.293.6729

Principal Investigator

Ubolrat Piamjariyakul

PRINCIPAL INVESTIGATOR

West Virginia University School of Nursing

Frequently Asked Questions

Who can join the NCT06791850 clinical trial?

This trial is open to participants of all sexes, aged 45 Years or older, up to 80 Years, studying Heart Failure NYHA Class III. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06791850 currently recruiting?

Yes, NCT06791850 is actively recruiting participants. Contact the research team at ubolrat.piamjariyakul@hsc.wvu.edu for enrollment information.

Where is the NCT06791850 trial being conducted?

This trial is being conducted at Morgantown, United States.

Who is sponsoring the NCT06791850 clinical trial?

NCT06791850 is sponsored by West Virginia University. The principal investigator is Ubolrat Piamjariyakul at West Virginia University School of Nursing. The trial plans to enroll 208 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology